ArticleEmerging microbes & infections2020

Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine.

Sebastian Schloer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.